Liver Diseases Treatment Market Size & Growth analysis by 2025

    Liver Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Diseases (Cirrhosis, Hepatitis, Cancer and Other Diseases), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities) and Geography

    Publication Month: Sep 2018 | Report Code: TIPMD00002089 | No. of Pages: 115 | Category: Medical Device | Status: Published

    The liver diseases treatment market is projected to reach US$ US$ 4,883.5 million by 2025 from US$ 3,426.8 million in 2017; it is expected to register a CAGR of 4.6% from 2018 to 2025.

    Liver is an organ that is situated just below the rib cage and on the right side of the abdomen. As essential function of liver is to carry out digestion of food and ridding off the body from toxic substances. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol. Over the time, damage to the liver results in scarring, a condition known as liver cirrhosis. The condition of liver can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.

    The report offers insights and in-depth analysis of the liver diseases treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. COVID-19 has been linked to liver illness in an increasing number of patients. Multiple mechanisms can contribute to COVID19 liver injury, including virus-induced systemic inflammation, hypoxia, hepatic congestion, and drug-induced liver disease. COVID-19 has been associated to hepatic decompensation and liver-related mortality in patients with liver cirrhosis. COVID-19's influence on healthcare resources has had a negative impact on chronic liver disease patient treatment and results. As a result, the treatment, diagnosis, and follow-up of individuals with liver disease has decreased, resulting in negative effects for the healthcare industry over the anticipated period. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Lucrative Regions for Liver Treatment Market

    Lucrative Regions for Liver Treatment Market

    Get more information on this report :


    Market Insights

    Rising Prevalence of Cardiovascular Diseases (CVDs)

    The geriatric population has been increasing rapidly as compared to the young population. As per data published by the United Nations, in 2017, there were an estimated 962 million people aged 60 or over in the world, which comprised of 13 per cent of the global population. The geriatric population is estimated to grow at a rate of 3 per cent per year. At present, Europe has the highest population aged 60 years and above. The ageing population in the world is projected to reach around 1.4 billion in 2030 and 2.1 billion in 2050 and is expected to reach up to 3.1 billion in 2100. Ageing has been linked with the severity and poor diagnosis of various liver diseases such as, alcoholic liver disease, nonalcoholic fatty liver disease, hepatitis C, and liver transplantation. Various structural as well as microscopic changes are seen in a liver while they are ageing. Its ability to metabolize many substances decreases gradually. Hence, the complications of liver disease also are more severe in the elderly. A study reported, an annual mortality rate of 50% among patients older than 60 years, compared to 7% in patients younger than 60. A report by the Centers for Disease Control and Prevention reported the death rates for chronic liver disease and cirrhosis rose 31% among those age 45 to 64 between 2000 and 2015.

    Disease-Based Insights

    Based on disease, the liver diseases treatment market is segmented into hepatitis, cirrhosis and cancer. In 2017, cancer held the largest market share. There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity. The segment is anticipated to grow with a CAGR of 5.2% during the forecast period.

    Liver Diseases treatment Market, by Disease – 2017 and 2025

    Liver Diseases treatment Market, by Disease – 2017 and 2025

    Get more information on this report :


    Imaging Modality-Based Insights

    Based on imaging modality, the liver treatment market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Other Imaging Modalities. Computed tomography (CT) segment is anticipated to grow at a CAGR of 4.7% during the forecast period. A CT scan provides accurate information about the size, shape and position of any tumors in the liver or elsewhere in the abdomen, as well as nearby blood vessels. Hence, it is used to identify the location of a tumor, analyze the extent of cancer in the body and also determine whether the disease is responding to treatments.

    Strategic Insights

    The liver treatment market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide as well as to meet the growing demand.


    By Diseases

    • Cirrhosis
    • Hepatitis
    • Cancer
    • Others

    By Imaging Modality

    • Static Cold Storage
    • Hypothermic Machine Perfusion
    • Normothermic Machine Perfusion
    • Others

    By

    Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • General Electric
    • Koninklijke Philips N.V.
    • Siemens AG
    • CANON MEDICAL SYSTEMS CORPORATION
    • Hitachi, Ltd
    • Elekta AB (pub)
    • Neusoft Corporation
    • Samsung Healthcare
    • BPL Medical Technologies
    • Cura Healthcare
    TABLE OF CONTENTS

    1. INTRODUCTION 14
    1.1 SCOPE OF THE STUDY 14
    1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 14

    2. GLOBAL LIVER TREATMENT MARKET – KEY TAKEAWAYS 15

    3. GLOBAL LIVER TREATMENT MARKET – MARKET LANDSCAPE 17
    3.1 OVERVIEW 17
    3.2 MARKET SEGMENTATION 17
    3.2.1 Global Liver Treatment Market – By Disease 18
    3.2.2 Global Liver Treatment Market – By Imaging Modality 18
    3.2.3 Global Liver Treatment Market – By Geography 19

    4. GLOBAL LIVER TREATMENT MARKET – KEY MARKET DYNAMICS 20
    4.1 KEY MARKET DRIVERS 20
    4.1.1 Increasing Prevalence of Liver Diseases 20
    4.1.2 Increasing Geriatric Population 20
    4.1.3 Technological Advancements in Imaging Techniques 21
    4.2 KEY MARKET RESTRAINTS 21
    4.2.1 Stringent Regulatory Validation Requirement 21
    4.2.2 High Cost of Imaging Techniques 21
    4.3 KEY MARKET OPPORTUNITIES 22
    4.3.1 Partnerships and Collaborations Between Market Players 22
    4.3.2 Increasing Healthcare Expenditures in Emerging Markets 22
    4.4 FUTURE TRENDS 23
    4.4.1 Increasing Use of Hybrid Systems for Imaging 23
    4.5 IMPACT ANALYSIS 24

    5. LIVER TREATMENT MARKET –GLOBAL ANALYSIS 25
    5.1 LIVER TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 25
    5.2 GLOBAL LIVER TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 25
    5.3 EXPERT OPINIONS 26

    6. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY DISEASES 27
    6.1 OVERVIEW 27
    6.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE 2017 & 2025 (%) 27
    6.3 CANCER MARKET 28
    6.3.1 Overview 28
    6.3.2 Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn) 28
    6.4 HEPATITIS MARKET 29
    6.4.1 Overview 29
    6.4.2 Global Hepatitis Market Revenue and Forecasts to 2025 (US$ Mn) 30
    6.5 CIRRHOSIS MARKET 31
    6.5.1 Overview 31
    6.5.2 Global Cirrhosis Market Revenue and Forecasts to 2025 (US$ Mn) 31
    6.6 OTHER DISEASES MARKET 32
    6.6.1 Overview 32
    6.6.2 Global Other Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 32

    7. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY IMAGING MODALITY 33
    7.1 OVERVIEW 33
    7.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY 2017 & 2025 (%) 33
    7.3 COMPUTED TOMOGRAPHY (CT) MARKET 34
    7.3.1 Overview 34
    7.3.2 Global Computed Tomography (CT) Market Revenue and Forecasts to 2025 (US$ Mn) 34
    7.4 MAGNETIC RESONANCE IMAGING (MRI) MARKET 35
    7.4.1 Overview 35
    7.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2025 (US$ Mn) 35
    7.6 ULTRASOUND MARKET 36
    7.6.1 Overview 36
    7.6.2 Global Ultrasound Market Revenue and Forecasts to 2025 (US$ Mn) 36
    7.7 OTHER IMAGING MODALITIES MARKET 37
    7.7.1 Overview 37
    7.7.2 Global Other Imaging Modalities Market Revenue and Forecasts to 2025 (US$ Mn) 37

    8. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 38
    8.1 OVERVIEW 38
    8.2 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
    8.3 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 39
    8.4 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 40
    8.5 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 40
    8.6 US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
    8.6.1 US Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 42
    8.6.2 US Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 42
    8.6.3 US Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 43
    8.7 CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
    8.7.1 Canada Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 44
    8.7.2 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 45
    8.7.3 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 45
    8.8 MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
    8.8.1 Mexico Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 46
    8.8.2 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 47
    8.8.3 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 47

    9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 48
    9.1 OVERVIEW 48
    9.2 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
    9.3 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
    9.4 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 50
    9.5 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
    9.6 GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
    9.6.1 Germany Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 51
    9.6.2 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
    9.6.3 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 52
    9.7 FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
    9.7.1 France Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 53
    9.7.2 France Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
    9.7.3 France Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 54
    9.8 UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
    9.8.1 UK Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 55
    9.8.2 UK Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56
    9.8.3 UK Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 56

    10. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 57
    10.1 OVERVIEW 57
    10.2 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
    10.3 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 58
    10.4 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 59
    10.5 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 59
    10.6 JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
    10.6.1 Japan Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 60
    10.6.2 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 61
    10.6.3 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 61
    10.7 CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
    10.7.1 China Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 62
    10.7.2 China Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 63
    10.7.3 China Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 63
    10.8 INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
    10.8.1 India Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 64
    10.8.2 India Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 65
    10.8.3 India Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 65

    11. MIDDLE EAST AND AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 66
    11.1 OVERVIEW 66
    11.2 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
    11.3 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 67
    11.4 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 68
    11.5 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 68
    11.6 UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
    11.6.1 UAE Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 69
    11.6.2 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 70
    11.6.3 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 70
    11.7 SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
    11.7.1 Saudi Arabia Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 71
    11.7.2 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
    11.7.3 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 72
    11.8 SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
    11.8.1 South Africa Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 73
    11.8.2 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
    11.8.3 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 74

    12. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 75
    12.1 OVERVIEW 75
    12.2 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
    12.3 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
    12.4 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 77
    12.5 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
    12.6 BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
    12.6.1 Brazil Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 78
    12.6.2 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 79
    12.6.3 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 79

    13. LIVER TREATMENT MARKET –KEY COMPANY PROFILES 80
    13.1 GENERAL ELECTRIC 80
    13.1.1 Key Facts 80
    13.1.2 Business Description 80
    13.1.3 Financial Overview 81
    13.1.4 Product Portfolio 81
    13.1.5 SWOT Analysis 82
    13.1.6 Key Developments 82
    13.2 KONINKLIJKE PHILIPS N.V. 83
    13.2.1 Key Facts 83
    13.2.2 Business Description 83
    13.2.3 Financial Overview 84
    13.2.4 Product Portfolio 84
    13.2.5 SWOT Analysis 85
    13.2.6 Key Developments 85
    13.3 SIEMENS AG 86
    13.3.1 Key Facts 86
    13.3.2 Business Description 86
    13.3.3 Financial Overview 87
    13.3.4 Product Portfolio 87
    13.3.5 SWOT Analysis 88
    13.3.6 Key Developments 88
    13.4 CANON MEDICAL SYSTEMS CORPORATION 89
    13.4.1 Key Facts 89
    13.4.2 Business Description 89
    13.4.3 Financial Overview 90
    13.4.4 Product Portfolio 90
    13.4.5 SWOT Analysis 91
    13.4.6 Key Developments 91
    13.5 HITACHI, LTD 92
    13.5.1 Key Facts 92
    13.5.2 Business Description 92
    13.5.3 Financial Overview 92
    13.5.4 Product Portfolio 93
    13.5.5 SWOT Analysis 93
    13.5.6 Key Developments 94
    13.6 ELEKTA AB (PUB) 95
    13.6.1 Key Facts 95
    13.6.2 Business Description 95
    13.6.3 Financial Overview 96
    13.6.4 Product Portfolio 96
    13.6.5 SWOT Analysis 97
    13.6.6 Key Developments 97
    13.7 NEUSOFT CORPORATION 98
    13.7.1 Key Facts 98
    13.7.2 Business Description 98
    13.7.3 Financial Overview 99
    13.7.4 Product Portfolio 99
    13.7.5 SWOT Analysis 100
    13.7.6 Key Developments 100
    13.8 SAMSUNG HEALTHCARE 101
    13.8.1 Key Facts 101
    13.8.2 Business Description 101
    13.8.3 Financial Overview 102
    13.8.4 Product Portfolio 102
    13.8.5 SWOT Analysis 102
    13.8.6 Key Developments 102
    13.9 BPL MEDICAL TECHNOLOGIES 103
    13.9.1 Key Facts 103
    13.9.2 Business Description 103
    13.9.3 Financial Overview 103
    13.9.4 Product Portfolio 103
    13.9.5 SWOT Analysis 104
    13.9.6 Key Developments 104
    13.10 CURA HEALTHCARE 105
    13.10.1 Key Facts 105
    13.10.2 Business Description 105
    13.10.3 Financial Overview 105
    13.10.4 Product Portfolio 106
    13.10.5 SWOT Analysis 106
    13.10.6 Key Developments 107

    14. APPENDIX 108
    14.1 ABOUT THE INSIGHT PARTNERS 108
    14.2 GLOSSARY OF TERMS 109
    14.3 METHODOLOGY 111
    14.3.1 Coverage 112
    14.3.2 Secondary Research 113
    14.3.3 Primary Research 113

    LIST OF TABLES

    TABLE 1. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 40
    TABLE 2. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 41
    TABLE 3. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 43
    TABLE 4. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 44
    TABLE 5. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 46
    TABLE 6. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 46
    TABLE 7. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 48
    TABLE 8. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 48
    TABLE 9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 50
    TABLE 10. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 51
    TABLE 11. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 53
    TABLE 12. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 53
    TABLE 13. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 55
    TABLE 14. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 55
    TABLE 15. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 57
    TABLE 16. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 57
    TABLE 17. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
    TABLE 18. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 60
    TABLE 19. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
    TABLE 20. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 62
    TABLE 21. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
    TABLE 22. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 64
    TABLE 23. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
    TABLE 24. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 66
    TABLE 25. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 68
    TABLE 26. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 69
    TABLE 27. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 71
    TABLE 28. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 71
    TABLE 29. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 73
    TABLE 30. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 73
    TABLE 31. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 75
    TABLE 32. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 75
    TABLE 33. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 77
    TABLE 34. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 78
    TABLE 35. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 80
    TABLE 36. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 80
    TABLE 37. GLOSSARY OF TERMS, LIVER TREATMENT MARKET 110

    LIST OF FIGURES

    FIGURE 1. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 16
    FIGURE 2. GLOBAL LIVER TREATMENT MARKET BY DISEASE, MARKET SHARE (%), 2017 17
    FIGURE 3. GLOBAL LIVER TREATMENT MARKET BY IMAGING MODALITY, MARKET SHARE (%), 2017 17
    FIGURE 4. LIVER TREATMENT MARKET SEGMENTATION 18
    FIGURE 5. LIVER TREATMENT SEGMENTATION, BY REGION 19
    FIGURE 6. LIVER TREATMENT MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 25
    FIGURE 7. GLOBAL LIVER TREATMENT MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 26
    FIGURE 8. GLOBAL LIVER TREATMENT MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 27
    FIGURE 9. GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE, 2017 & 2025 (%) 28
    FIGURE 10. GLOBAL CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 29
    FIGURE 11. GLOBAL HEPATITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 31
    FIGURE 12. GLOBAL CIRRHOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 32
    FIGURE 13. GLOBAL OTHER DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 33
    FIGURE 14. GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY, 2017 & 2025 (%) 34
    FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
    FIGURE 16. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
    FIGURE 17. GLOBAL ULTRASOUND MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 37
    FIGURE 18. GLOBAL OTHER IMAGING MODALITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
    FIGURE 19. NORTH AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 39
    FIGURE 20. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
    FIGURE 21. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 41
    FIGURE 22. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
    FIGURE 23. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
    FIGURE 24. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
    FIGURE 25. EUROPE LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 49
    FIGURE 26. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
    FIGURE 27. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 51
    FIGURE 28. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
    FIGURE 29. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
    FIGURE 30. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
    FIGURE 31. ASIA PACIFIC LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 58
    FIGURE 32. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
    FIGURE 33. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
    FIGURE 34. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
    FIGURE 35. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
    FIGURE 36. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
    FIGURE 37. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 67
    FIGURE 38. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
    FIGURE 39. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
    FIGURE 40. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
    FIGURE 41. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
    FIGURE 42. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
    FIGURE 43. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 76
    FIGURE 44. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
    FIGURE 45. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 78
    FIGURE 46. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79

    The List of Companies

    1. General Electric
    2. Koninklijke Philips N.V.
    3. Siemens AG
    4. CANON MEDICAL SYSTEMS CORPORATION
    5. Hitachi, Ltd
    6. Elekta AB (pub)
    7. Neusoft Corporation
    8. Samsung Healthcare
    9. BPL Medical Technologies
    10. Cura Healthcare

    Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liver treatment market.

    -Highlights key business priorities in order to assist companies to realign their business strategies.

    -The key findings and recommendations highlight crucial progressive industry trends in the global liver treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

    -Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

    -Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

    -Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPMD00002089
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550 $3000
    • $6550 $4000
    • $8550 $5000
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount